BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32884573)

  • 1. Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma.
    Wang X; Li K; Cheng M; Wang G; Han H; Chen F; Liao W; Chen Z; Chen J; Bao Y; Peng L; Chen D
    Stem Cells Int; 2020; 2020():8877577. PubMed ID: 32884573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma
    Wang J; Ji H; Zhu Q; Yu X; Du J; Jiang Z
    Oncol Lett; 2019 Jun; 17(6):5012-5022. PubMed ID: 31186712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
    Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
    Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
    Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
    Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and survival significance of B-cell-specific Moloney murine leukemia virus integration site 1 and matrix metalloproteinase-9 in non-small-cell lung cancer.
    Mu M; Song Y; Zhang B
    Oncol Lett; 2016 Nov; 12(5):3715-3722. PubMed ID: 27900059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
    Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
    Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma.
    Ana Choi SS; Ko JM; Yu VZ; Ning L; Lung ML
    Oncol Lett; 2021 Jul; 22(1):513. PubMed ID: 33986873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
    Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
    Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
    Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
    EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
    Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
    J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.